February 13, 2023, VANCOUVER, BC – Arbutus Medical Inc., a medical device company developing innovative surgical drill technology and sterile-packed orthopaedic procedure kits, has announced a $2.26MM financing jointly led by Genome British Columbia and Vancouver-based health technology venture fund Nimbus Synergies.

Genome BC has initially invested $1.13 million with potential further funding of $0.37 million as Arbutus Medical expands its investment syndicate throughout Q1 2023. Genome BC’s investment is made through its Industry Innovation (I²) Fund, which provides commercialization support for BC companies developing innovative life science technologies. Nimbus Synergies makes a follow-on investment after leading Arbutus Medical’s Seed Round. Syndicate partners include the Pan-Canadian consortium MEDTEQ+, ScaleGood Impact Fund, and ThresholdImpact.

Read the press release